Ceftriaxone protects against the neurotoxicity of human immunodeficiency virus proteins

References

• Anderson C M, Swanson R A. Astrocyte glutamate transport: review of properties, regulation, and physiological functions. Glia 2000; 32: 1–14
   PubMed Web of Science ®Google Scholar
• Bansal A K, Mactutus C F, Nath A, Maragos W, Hauser K F, Booze R M. Neurotoxicity of HIV-1 proteins gp120 and Tat in the rat striatum. Brain Res 2000; 879: 42–49
   Google Scholar
• Billaud J N, Selway D, Yu N, Phillips T R. Replication rate of feline immunodeficiency virus in astrocytes is envelope dependent: implications for glutamate uptake. Virology 2000; 266: 180–188
   Google Scholar
• Chen P, Mayne M, Power C, Nath A. The Tat protein of HIV-1 induces tumor necrosis factor-α production: Implications for HIV associated neurological diseases. J Biol Chem 1997; 272: 22385–22388
   PubMed Web of Science ®Google Scholar
• Corasaniti M T, Bellizzi C, Russo R, Colica C, Amantea D, Di Renzo G. Caspase-1 inhibitors abolish deleterious enhancement of COX-2 expression induced by HIV-1 gp120 in human neuroblastoma cells. Toxicol Lett 2003; 139: 213–219
   Google Scholar
• Dore G J, McDonald A, Li Y, Kaldor J M, Brew B J. Marked improvement in survival following AIDS dementia complex in the era of highly active antiretroviral therapy. AIDS 2003; 17: 1539–1545
   PubMed Web of Science ®Google Scholar
• Drejer J, Meier E, Schousboe A. Novel neuron-related regulatory mechanisms for astrocytic glutamate and GABA high affinity uptake. Neurosci Lett 1983; 37: 301–306
   Google Scholar
• Haughey N J, Nath A, Mattson M P, Slevin J T, Geiger J D. HIV-1 Tat through phosphorylation of NMDA receptors potentiates glutamate excitotoxicity. J Neurochem 2001; 78: 457–467
   PubMed Web of Science ®Google Scholar
• Lafortune L, Nalbantoglu J, Antel J P. Expression of tumor necrosis factor alpha (TNF alpha) and interleukin 6 (IL-6) mRNA in adult human astrocytes: comparison with adult microglia and fetal astrocytes. J Neuropathol Exp Neurol 1996; 55: 515–521
   Google Scholar
• Lipton S A. AIDS related dementia and calcium homeostasis. Ann N Y Acad Sci 1994; 594: 189–196
   Google Scholar
• Ma M, Nath A. Molecular determinants for cellular uptake of Tat protein of human immunodeficiency virus type 1 in brain cells. J Virol 1997; 71: 2495–2499
   PubMed Web of Science ®Google Scholar
• Magnuson D S, Knudsen B E, Geiger J D, Brownstone R M, Nath A. Human immunodeficiency virus type 1 tat activates non-N-methyl-d-aspartate excitatory amino acid receptors and causes neurotoxicity. Ann Neurol 1995; 37: 373–380
   PubMed Web of Science ®Google Scholar
• McArthur J C, Haughey N, Gartner S, Conant K, Pardo C, Nath A, Sacktor N. Human immunodeficiency virus-associated dementia: an evolving disease. J NeuroVirol 2003; 9: 205–221
   PubMed Web of Science ®Google Scholar
• Nath A, Haughey N J, Jones M, Anderson C, Bell J E, Geiger J D. Synergistic neurotoxicity by human immunodeficiency virus proteins Tat and gp120: protection by memantine. Ann Neurol 2000; 47: 186–194
   PubMed Web of Science ®Google Scholar
• Nath A, Psooy K, Martin C, Knudsen B, Magnuson D S, Haughey N, Geiger J D. Identification of a human immunodeficiency virus type 1 Tat epitope that is neuroexcitatory and neurotoxic. J Virol 1996; 70: 1475–1480
   PubMed Web of Science ®Google Scholar
• Neuenburg J K, Brodt H R, Herndier B G, Bickel M, Bacchetti P, Price R W, Grant R M, Schlote W. HIV-related neuropathology, 1985 to 1999: rising prevalence of HIV encephalopathy in the era of highly active antiretroviral therapy. J Acquir Immune Defic Syndr 2002; 31: 171–177
   PubMed Web of Science ®Google Scholar
• Olsen C, Rustad A, Fonnum F, Paulsen R E, Hassel B. 3-Nitropropionic acid: an astrocyte-sparing neurotoxin in vitro. Brain Res 1999; 850: 144–149
   Google Scholar
• Prendergast M A, Rogers D T, Mulholland P J, Littleton J M, Wilkins L H, Jr., Self R L, Nath A. Neurotoxic effects of the human immunodeficiency virus type-1 transcription factor Tat require function of a polyamine sensitive-site on the N-methyl-D-aspartate receptor. Brain Res 2002; 954: 300–307
   Web of Science ®Google Scholar
• Ranki A, Nyberg M, Ovod V, Haltia M, Elovaara I, Raininko R, Haapasalo H, Krohn K. Abundant expression of HIV Nef and Rev proteins in brain astrocytes in vivo is associated with dementia. AIDS 1995; 9: 1001–1008
   PubMed Web of Science ®Google Scholar
• Robinson M B. The family of sodium-dependent glutamate transporters: a focus on the GLT-1/EAAT2 subtype. Neurochem Int 1998; 33: 479–491
   PubMed Web of Science ®Google Scholar
• Rosen C A, Terwilliger E, Dayton A, Sodroski J G, Haseltine W A. Intragenic cis-acting art gene-responsive sequences of the human immunodeficiency virus. Proc Natl Acad Sci USA 1988; 85: 2071–2075
   PubMedGoogle Scholar
• Rothstein J D, Patel S, Regan M R, Haenggeli C, Huang Y H, Bergles D E, Jin L, Dykes Hoberg M, Vidensky S, Chung D S, Toan S V, Bruijn L I, Su Z Z, Gupta P, Fisher P B. Beta-lactam antibiotics offer neuroprotection by increasing glutamate transporter expression. Nature 2005; 433: 73–77
   PubMed Web of Science ®Google Scholar
• Sacktor N. The epidemiology of human immunodeficiency virus-associated neurological disease in the era of highly active antiretroviral therapy. J NeuroVirol 2002; 8: 115–121, (Suppl 2)
   PubMed Web of Science ®Google Scholar
• Sacktor N, McDermott M P, Marder K, Schifitto G, Selnes O A, McArthur J C, Stern Y, Albert S, Palumbo D, Kieburtz K, De Marcaida J A, Cohen B, Epstein L. HIV-associated cognitive impairment before and after the advent of combination therapy. J NeuroVirol 2002; 8: 136–142
   PubMed Web of Science ®Google Scholar
• Saito Y, Sharer L R, Epstein L G, Michaels J, Mintz M, Louder M, Golding K, Cvetkovich T A, Blumberg B M. Overexpression of nef as a marker for restricted HIV-1 infection of astrocytes in postmortem pediatric central nervous tissues. Neurology 1994; 44: 474–481
   PubMed Web of Science ®Google Scholar
• Scheld W M, Rocha H, Sande M A, Bryan J P. Rationale for clinical trials evaluating ceftriaxone in the therapy of bacterial meningitis. Am J Med 1984; 77: 42–49
   PubMed Web of Science ®Google Scholar
• Szymocha R, Akaoka H, Dutuit M, Malcus C, Didier-Bazes M, Belin M F, Giraudon P. Human T-cell lymphotropic virus type 1-infected T lymphocytes impair catabolism and uptake of glutamate by astrocytes via Tax-1 and tumor necrosis factor alpha. J Virol 2000; 74: 6433–6441
   PubMed Web of Science ®Google Scholar
• Tornatore C, Chandra R, Berger J R, Major E O. HIV-1 infection of subcortical astrocytes in the pediatric central nervous system. Neurology 1994; 44: 481–487
   PubMed Web of Science ®Google Scholar
• Turchan J, Anderson C, Hauser K F, Sun Q, Zhang J, Liu Y, Wise P M, Kruman I, Maragos W, Mattson M P, Booze R, Nath A. Estrogen protects against the synergistic toxicity by HIV proteins, methamphetamine and cocaine. BMC Neurosci 2001; 2: 3
   Web of Science ®Google Scholar
• Wahl L M, Corcoran M L, Pyle S W, Arthur L O, Harel-Bellan A, Farrar W L. Human immunodeficiency virus glycoprotein (gp120) induction of monocyte arachidonic acid metabolites and interleukin 1. Proc Natl Acad Sci USA 1989; 86: 621–625
   PubMed Web of Science ®Google Scholar
• Wang Z, Pekarskaya O, Bencheikh M, Chao W, Gelbard H A, Ghorpade A, Rothstein J D, Volsky D J. Reduced expression of glutamate transporter EAAT2 and impaired glutamate transport in human primary astrocytes exposed to HIV-1 or gp120. Virology 2003; 312: 60–73
   PubMed Web of Science ®Google Scholar
• Wang Z, Trillo-Pazos G, Kim S Y, Canki M, Morgello S, Sharer L R, Gelbard H A, Su Z Z, Kang D C, Brooks A I, Fisher P B, Volsky D J. Effects of human immunodeficiency virus type 1 on astrocyte gene expression and function: potential role in neuropathogenesis. J NeuroVirol 2004; 10: 25–32, (Suppl 1)
   PubMed Web of Science ®Google Scholar
• Yu N, Billaud J N, Phillips T R. Effects of feline immunodeficiency virus on astrocyte glutamate uptake: implications for lentivirus-induced central nervous system diseases. Proc Natl Acad Sci USA 1998; 95: 2624–2629
   Google Scholar